A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.This article was originally published on MedicalXpress.com
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.This article was originally published on MedicalXpress.com
New research presented at the European Congress on Obesity (ECO2025) in Malaga, Spain (11–14 May) reveals that adverse waist-to-height ratio trajectories (a marker for central obesity) during childhood may increase cardiometabolic and cardiovascular risk at […]
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous clinical trials. The findings are published […]
Individuals who lived with obesity as children are less likely to be in work or studying in their mid-20s than their peers, new research presented at the European Congress on Obesity (ECO 2025) has found.This […]
Personalized feedback interventions (PFIs), a common strategy for helping college students moderate their alcohol use, can reduce drinking and its negative consequences. But such interventions vary by length and complexity, and targeting them strategically—considering users’ […]
Childhood overweight and obesity are a growing public health challenge in South Africa. In 2016, 13% of the country’s children were reported to be obese. This is predicted to double by 2030.This article was originally […]
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a new therapeutic pathway for cancers driven by NRAS mutations. Findings suggest that interfering with specific protein […]
For neurodegenerative diseases such as Alzheimer’s and Parkinson’s, treatment options are scant. New research by Stanford scientists illuminates a promising target for treatment—increasing a lipid that boosts the trash-sorting functions of cells.This article was originally […]
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the journal eClinicalMedicine finds that first-generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer […]
© 2025 SimplyWell.ca